Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Oct;76(4):1695-8.
doi: 10.1172/JCI112157.

Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism

Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism

M Akmal et al. J Clin Invest. 1985 Oct.

Abstract

The human erythrocyte (RBC) is a target organ for parathyroid hormone (PTH) and the hormone increases RBC osmotic fragility and induces their hemolysis. The present study was undertaken to examine whether elevated blood levels of PTH affect RBC survival, and therefore whether PTH, being an extracorpuscular factor, is responsible for the shortened RBC survival in chronic renal failure. 51Cr-labeled RBC survival was elevated in six normal dogs, in six animals with chronic renal failure and secondary hyperparathyroidism (NPX), and in six thyroparathyroidectomized dogs (NPX-TPTX) with comparable degree and duration of chronic renal failure. In the normal dogs, 51Cr-labeled RBC survival ranged between 22 and 35 (25.6 +/- 1.9) d. In the NPX dogs, 51Cr-labeled RBC survival was shortened and the values ranged between 16 and 20 (18.4 +/- 0.6) d, a value significantly (P less than 0.01) lower than normal dogs. In NPX-TPTX dogs, 51Cr-labeled RBC survival ranged between 20 and 33 (25.2 +/- 1.8) d, a value not different from that in normal dogs but significantly higher (P less than 0.01) than that in NPX animals. Our data demonstrate that excess blood levels of PTH and not other consequences of the uremic state are responsible for the shortened RBC survival in chronic renal failure.

PubMed Disclaimer

References

    1. Medicine (Baltimore). 1969 Sep;48(5):333-74 - PubMed
    1. Clin Nephrol. 1983 May;19(5):232-5 - PubMed
    1. AMA Arch Intern Med. 1958 Feb;101(2):326-32 - PubMed
    1. Clin Sci (Lond). 1985 Jan;68(1):29-33 - PubMed
    1. J Clin Invest. 1982 Apr;69(4):1017-25 - PubMed

Publication types